It is also known as folate hydrolase 1 (FOLH1), glutamate carboxypeptidase II (GCPII), or N-acetyl-α-linked acidic dipeptidase I. PSMA is highly overexpressed in more than 85% of patients with prostate cancer [68]. Here, FOLH1 is linked to prostate carcinoma.